
Ionis Pharmaceuticals Inc. (NASDAQ:IONS) closed regular trading at $42.81, up 0.78% for the day, before gaining an additional 2.38% in premarket trading to $43.83, according to Benzinga Pro data, following disclosure of insider trading activity by its chief scientific officer.
Check out the current price of IONS stock here.